Hemodynamic Effects of Ketone Bodies in Patients With Pulmonary Hypertension

BACKGROUND: Pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH) are debilitating diseases with a high mortality. Despite emerging treatments, pulmonary vascular resistance frequently remains elevated. However, the ketone body 3‐hydroxybutyrate (3‐OHB) may r...

Descripción completa

Detalles Bibliográficos
Autores principales: Nielsen, Roni, Christensen, Kristian Hylleberg, Gopalasingam, Nigopan, Berg‐Hansen, Kristoffer, Seefeldt, Jacob, Homilius, Casper, Boedtkjer, Ebbe, Andersen, Mads Jønsson, Wiggers, Henrik, Møller, Niels, Bøtker, Hans Erik, Mellemkjær, Søren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227291/
https://www.ncbi.nlm.nih.gov/pubmed/37183871
http://dx.doi.org/10.1161/JAHA.122.028232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227291/
https://www.ncbi.nlm.nih.gov/pubmed/37183871
http://dx.doi.org/10.1161/JAHA.122.028232

Ejemplares similares